1. Jung KW, Won YJ, Kong HJ, Lee ES. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2016. Cancer Res Treat 2019;51:417–30.

2. Mullan F. Seasons of survival: reflections of a physician with cancer. N Engl J Med 1985;313:270–3.

3. Goo AJ, Song YM, Shin J, Ko H. Factors associated with depression assessed by the patient health questionnaire-2 in long-term cancer survivors. Korean J Fam Med 2016;37:228–34.

4. Park W, Lee JK, Kim CR, Shin JY. Factors associated with fatigue in Korean gastric cancer survivors. Korean J Fam Med 2015;36:328–34.

5. Ligibel JA, Denlinger CS. New NCCN guidelines for survivorship care. J Natl Compr Canc Netw 2013;11:640–4.

6. Lee KS, Chang HS, Lee SM, Park EC. Economic burden of cancer in Korea during 2000-2010. Cancer Res Treat 2015;47:387–98.

7. Shin DW, Cho B, Kim SY, Jung JH, Park JH. Management of cancer survivors in clinical and public health perspectives: current status and future challenges in Korea. J Korean Med Sci 2013;28:651–7.

8. Kim J, Hahm MI, Park EC, Park JH, Park JH, Kim SE, et al. Economic burden of cancer in South Korea for the year 2005. J Prev Med Public Health 2009;42:190–8.

9. Cho J, Guallar E, Hsu YJ, Shin DW, Lee WC. A comparison of cancer screening practices in cancer survivors and in the general population: the Korean national health and nutrition examination survey (KNHANES) 2001-2007. Cancer Causes Control 2010;21:2203–12.

10. Patnaik JL, Byers T, Diguiseppi C, Denberg TD, Dabelea D. The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst 2011;103:1101–11.

11. Shin DW, Nam JH, Kwon YC, Park SY, Bae DS, Park CT, et al. Comorbidity in disease-free survivors of cervical cancer compared with the general female population. Oncology 2008;74:207–15.

12. Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer 2004;101:1712–9.

13. Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 2010;340:b5569.

14. Park YM IH, Shin DW, Yun JM, Seo BS. Analysis of health behaviors and medical use of cancer survivors. Goyang: National Health Insurance Service Ilsan Hospital; 2015. 15. Park JJ, Park HA. Prevalence of cigarette smoking among adult cancer survivors in Korea. Yonsei Med J 2015;56:556–62.

16. Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, et al. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 2006;24:3527–34.

17. Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvao DA, Pinto BM, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 2010;42:1409–26.

18. Schattner M, Shike M. Nutrition support of the patient with cancer. In: Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ, editor. Modern nutrition in health and disease. 10th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2006. p. 1290–313. 19. Carmichael AR. Obesity and prognosis of breast cancer. Obes Rev 2006;7:333–40.

20. Siegel EM, Ulrich CM, Poole EM, Holmes RS, Jacobsen PB, Shibata D. The effects of obesity and obesity-related conditions on colorectal cancer prognosis. Cancer Control 2010;17:52–7.

21. Capuano G, Grosso A, Gentile PC, Battista M, Bianciardi F, Di Palma A, et al. Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy. Head Neck 2008;30:503–8.

22. Lee JH, Kim JG, Jung HK, Kim JH, Jeong WK, Jeon TJ, et al. Synopsis on clinical practice guideline of gastric cancer in Korea: an evidencebased approach. Korean J Gastroenterol 2014;63:66–81.

23. Cardoso R, Coburn NG, Seevaratnam R, Mahar A, Helyer L, Law C, et al. A systematic review of patient surveillance after curative gastrectomy for gastric cancer: a brief review. Gastric Cancer 2012;15:S164–7.

24. Sano T, Sasako M, Kinoshita T, Maruyama K. Recurrence of early gastric cancer: follow-up of 1475 patients and review of the Japanese literature. Cancer 1993;72:3174–8.

25. Shin DW, Yoo SH, Sunwoo S, Yoo MW. Management of long-term gastric cancer survivors in Korea. J Korean Med Assoc 2016;59:256–65.

26. Seo HK, Park JH. Evidence based cancer survival management. Goyang: National Cancer Center; 2013. 27. Tabuchi T, Ito Y, Ioka A, Miyashiro I, Tsukuma H. Incidence of metachronous second primary cancers in Osaka, Japan: update of analyses using population-based cancer registry data. Cancer Sci 2012;103:1111–20.

28. Korean Association for Lung Cancer. Lung cancer clinical practice guideline. Seoul: Korean Association for Lung Cancer; 2011. 29. Chae BJ, Song BJ, Jung SS. Postoperative treatment strategy and follow up management for breast cancer patients in Korea. Korean J Clin Oncol 2009;5:21–6.

30. Yi KH, Lee EK, Kang HC, Koh Y, Kim SW, Kim IJ, et al. 2016 Revised Korean thyroid association management guidelines for patients with thyroid nodules and thyroid cancer. Int J Thyroidol 2016;9:59–126.

31. Korean Society of Gynecologic Oncology. Practice guideline for gynecologic cancer. 3rd ed. Seoul: Korean Society of Gynecologic Oncology; 2016. 32. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: colon cancer. 2nd ed. Plymouth Meeting (PA): National Comprehensive Cancer Network; 2019. 33. Scholefield JH, Steele RJ, British Society For Gastroenterology; Association of Coloproctology for Great Britain and Ireland. Guidelines for follow up after resection of colorectal cancer. Gut 2002;51:V3–5.

34. Hwang C. Follow-up colonoscopy after colorectal cancer surgery. Korean J Gastrointest Endosc 2003;27:297–9. 35. Weaver KE, Foraker RE, Alfano CM, Rowland JH, Arora NK, Bellizzi KM, et al. Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Surviv 2013;7:253–61.

36. Khan NF, Mant D, Carpenter L, Forman D, Rose PW. Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study. Br J Cancer 2011;105:S29–37.

37. Jansen L, Hoffmeister M, Chang-Claude J, Koch M, Brenner H, Arndt V. Age-specific administration of chemotherapy and long-term quality of life in stage II and III colorectal cancer patients: a population-based prospective cohort. Oncologist 2011;16:1741–51.

38. Lou F, Huang J, Sima CS, Dycoco J, Rusch V, Bach PB. Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance. J Thorac Cardiovasc Surg 2013;145:75–81.

39. Yun YH, Kim YA, Min YH, Chang YJ, Lee J, Kim MS, et al. Health-related quality of life in disease-free survivors of surgically treated lung cancer compared with the general population. Ann Surg 2012;255:1000–7.

40. Kravchenko J, Berry M, Arbeev K, Lyerly HK, Yashin A, Akushevich I. Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis. Lung Cancer 2015;88:85–93.

41. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Impact of comorbidity on lung cancer survival. Int J Cancer 2003;103:792–802.

42. Korean Breast Cancer Society. The 6th Korean clinical practice recommendations of breast cancer. 6th ed. Seoul: Korean Breast Cancer Society; 2015. 43. Calip GS, Yu O, Hoskins KF, Boudreau DM. Associations between diabetes medication use and risk of second breast cancer events and mortality. Cancer Causes Control 2015;26:1065–77.

44. Wasan KM, Goss PE, Pritchard PH, Shepherd L, Palmer MJ, Liu S, et al. The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA.17L). Ann Oncol 2005;16:707–15.

45. Chen Z, Maricic M, Pettinger M, Ritenbaugh C, Lopez AM, Barad DH, et al. Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer. Cancer 2005;104:1520–30.

46. Sawin CT. Subclinical hyperthyroidism and atrial fibrillation. Thyroid 2002;12:501–3.

47. Donangelo I, Braunstein GD. Update on subclinical hyperthyroidism. Am Fam Physician 2011;83:933–8.

48. Nead KT, Gaskin G, Chester C, Swisher-McClure S, Leeper NJ, Shah NH. Association between androgen deprivation therapy and risk of dementia. JAMA Oncol 2017;3:49–55.

49. Wenzel L, DeAlba I, Habbal R, Kluhsman BC, Fairclough D, Krebs LU, et al. Quality of life in long-term cervical cancer survivors. Gynecol Oncol 2005;97:310–7.

50. Shin DW, Kim Y, Baek YJ, Mo HN, Choi JY, Cho J. Oncologists experience with second primary cancer screening: current practices and barriers and potential solutions. Asian Pac J Cancer Prev 2012;13:671–6.

51. Hewitt ME, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington (DC): National Academies Press; 2006. 52. Grunfeld E, Levine MN, Julian JA, Coyle D, Szechtman B, Mirsky D, et al. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol 2006;24:848–55.

53. Susanibar S, Thrush CR, Khatri N, Hutchins LF. Cancer survivorship training: a pilot study examining the educational gap in primary care medicine residency programs. J Cancer Surviv 2014;8:565–70.

54. Shin DW, Kim YW, Oh JH, Kim SW, Chung KW, Lee WY, Let al. Knowledge, attitudes, risk perception, and cancer screening behaviors among cancer survivors. Cancer 2011;117:3850–9.

55. Shin DW, Park JH, Park JH, Park EC, Kim SY, Kim SG, et al. Antihypertensive medication adherence in cancer survivors and its affecting factors: results of a Korean population-based study. Support Care Cancer 2010;19:211–20.

56. Halpern MT, Viswanathan M, Evans TS, Birken SA, Basch E, Mayer DK. Models of cancer survivorship care: overview and summary of current evidence. J Oncol Pract 2015;11:e19–27.

57. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, part 2. JAMA 2002;288:1909–14.

58. Oeffinger KC, McCabe MS. Models for delivering survivorship care. J Clin Oncol 2006;24:5117–24.

59. Emery JD, Jefford M, King M, Hayne D, Martin A, Doorey J, et al. ProCare trial: a phase II randomized controlled trial of shared care for follow-up of men with prostate cancer. BJU Int 2017;119:381–9.

60. Cheung WY, Neville BA, Cameron DB, Cook EF, Earle CC. Comparisons of patient and physician expectations for cancer survivorship care. J Clin Oncol 2009;27:2489–95.

61. Mao JJ, Bowman MA, Stricker CT, DeMichele A, Jacobs L, Chan D, et al. Delivery of survivorship care by primary care physicians: the perspective of breast cancer patients. J Clin Oncol 2009;27:933–8.